Categories 2022 Press Releases The Board Of Directors Approves The Appointment By Co-Option Of A New Independent Director Post author By Antonio Buono Post date 29 December 2022 The Board Of Directors Approves The Appointment By Co-Option Of A New Independent Director ← Farmacosmo Purchases 67% Of Innovation Pharma S.R.L., Owner Of Two Pharmacies In Northern Italy. The Strategy Of Rooting The Logistics Pharmacies Under The Farmacosmo Brand Continues. → Il Consiglio Di Amministrazione Approva La Nomina Per Cooptazione Di Un Nuovo Consigliere Indipendente
Farmacosmo InvestorsFarmacosmo Investors